DRUG RETENTION OF BIOLOGIC AND TARGETED SYNTHETIC DMARDS IN KOREAN SEROPOSITIVE RHEUMATOID ARTHRITIS (RA) PATIENTS: A REALWORLD SINGLE-CENTER RETROSPECTIVE STUDY

被引：0
|
作者：
Lee, B. W. [1 ]
Lee, J. J. [1 ]
Kim, W. U. [1 ]
机构：
[1] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Rheumatol,Dept Internal Med, Seoul, South Korea
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Rheumatoid arthritis; Targeted synthetic drugs; bDMARD;
D O I：
10.1136/annrheumdis-2023-eular.3677
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0854
引用
收藏
页码：730 / 731
页数：2
相关论文
共 50 条
  • [1] Drug retention of biologic and targeted synthetic disease-modifying antirheumatic drugs in Korean patients with seropositive rheumatoid arthritis
    Lee, Bong -Woo
    Lee, Jennifer Jooha
    Kim, Wan-Uk
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2024, 39 (05): : 833 - +
  • [2] Treatment Persistence Among Medicare Beneficiaries with Seropositive Rheumatoid Arthritis Initiating Biologic or Targeted Synthetic DMARDs
    Park, Sang Hee
    Schwartz, Taylor
    Han, Xue
    Robinson, Scott
    Kakehi, Sumie
    Wittstock, Keith
    Norris, Kris
    Murunga, Anne
    Silverstein, Alison
    Sparks, Jeffrey
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 957 - 958
  • [3] COVID-19 outcomes in patients with rheumatoid arthritis with biologic or targeted synthetic DMARDs
    Tsai, Jih-Jin
    Liu, Li-Teh
    Chen, Chun-Hong
    Chen, Liang-Jen
    Wang, Shiow-Ing
    Wei, James Cheng-Chung
    RMD OPEN, 2023, 9 (03):
  • [4] THE RETENTION RATES OF THE SECOND BIOLOGIC AGENTS IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO TNFα INHIBITORS, SINGLE-CENTER, RETROSPECTIVE, OBSERVATIONAL STUDY
    Kikuchi, E.
    Uekubo, K.
    Aoki, N.
    Yoshioka, T.
    Okai, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1021 - 1021
  • [5] Characteristics of Tuberculosis in Patients with Rheumatoid Arthritis: A Retrospective Single-center Study
    Ishiguro, Takashi
    Takayanagi, Noboru
    Kagiyama, Naho
    Yanagisawa, Tsutomu
    Sugita, Yutaka
    INTERNAL MEDICINE, 2014, 53 (12) : 1291 - 1298
  • [6] Temporal and regional variation in the use of biologic and targeted synthetic DMARDs for rheumatoid arthritis: a nationwide cohort study
    Russell, Mark D.
    Yang, Zijing
    Dooley, Niamh
    Gibson, Mark
    Zuckerman, Benjamin
    Adas, Maryam A.
    Alveyn, Edward
    Patel, Samir
    Bechman, Katie
    Price, Elizabeth
    Gallagher, Sarah
    Coalwood, Callum
    Cope, Andrew P.
    Norton, Sam
    Galloway, James B.
    RHEUMATOLOGY, 2024,
  • [7] RITUXIMAB VERSUS ABATACEPT IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE RESPONSE TO PRIOR BIOLOGIC THERAPY: A RETROSPECTIVE SINGLE-CENTER STUDY
    Keystone, E.
    Weber, D.
    Xiong, J.
    Sun, Y.
    Grant, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 449 - 450
  • [8] Rituximab versus Abatacept in Rheumatoid Arthritis Patients with an Inadequate Response to Prior Biologic Therapy: A Retrospective Single-Center Study
    Keystone, Edward
    Weber, Deborah
    Xiong, Juan
    Sun, Ye
    Grant, Alex
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1456 - 1457
  • [9] Rituximab Versus Abatacept in Rheumatoid Arthritis Patients with an Inadequate Response to Prior Biologic Therapy: A Retrospective, Single-Center Study
    Keystone, Edward
    Xiong, Juan
    Weber, Deborah
    Sun, Ye
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S557 - S557
  • [10] Rituximab versus Abatacept in Rheumatoid Arthritis Patients with an Inadequate Response to Prior Biologic Therapy: A Retrospective Single-Center Study
    Keystone, Edward
    Xiong, Juan
    Weber, Debrah
    Sun, Ye
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 995 - 996
12345